AMPEL BioSolutions
Peter Lipsky is the CEO/CMO of AMPEL BioSolutions and has been involved in the Lupus Clinical Investigator Network. Prior to that, Peter worked as a consultant and held various leadership roles at different institutions. Lipsky holds a Doctor of Medicine degree from New York Medicine Jobs and a Bachelor of Arts degree from Cornell University.
AMPEL BioSolutions
Precision medicine company commercializing LDTs that predict disease status, molecular pathways and best drug options.